FDA
approval
· 2023-02-28
FDA Approved: GANIRELIX ACETATE — Original Application (Fresenius Kabi USA, LLC)
Summary
The FDA approved Fresenius Kabi USA, LLC's original application for ganirelix acetate, a GnRH antagonist used to prevent premature LH surge during controlled ov…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for GANIRELIX ACETATE (GANIRELIX ACETATE)